论文部分内容阅读
目的分析肺结核巩固治疗其患者服药依从性现状,探讨进行个体干预对服药依从性的影响效果。方法选取80例肺结核巩固治疗期患者,通过慢性疾病患者服药依从性量表对其服药依从性现状进行统计分析,然后将80例患者均分为研究组和对照组,对40例研究组患者进行除常规治疗外的个人化干预措施,40例对照组患者除常规治疗外不进行干预措施,然后对比两组患者服药依从性。结果肺结核巩固期治疗期患者服药依从性较低,研究组和对照组干预前服药依从性得分分别为为(3.82±1.24)分和(3.79±1.13);研究组患者经过3个月的干预治疗后,服药依从性均分为(6.92±0.99)分,较治疗前相比得分显著提高(P<0.05),与治疗后的对照组患者服药依从性相比差异显著具有统计学意义(P<0.05);对照组患者与3月前相比,服药依从性得分变化不明显(P>0.05)。结论肺结核巩固治疗期患者服药依从性较低,经过个体化的干预治疗后可以显著提高其服药依从性。
Objective To analyze the compliance status of patients with pulmonary tuberculosis undergoing consolidation therapy and to explore the effect of individual intervention on medication adherence. Methods Eighty patients with consolidation stage of pulmonary tuberculosis were enrolled in this study. The compliance status of patients with chronic diseases was analyzed by statistical analysis. The 80 patients were divided into study group and control group, 40 patients in study group In addition to routine treatment of individual interventions, 40 patients in the control group, except for conventional treatment without intervention, and then compared the two groups of patients compliance. Results The treatment compliance of patients during the consolidation phase of pulmonary tuberculosis was relatively low. The medication compliance scores of the study group and the control group before treatment were (3.82 ± 1.24) points and (3.79 ± 1.13) respectively. The study group were treated with 3-month intervention (6.92 ± 0.99) points, which was significantly higher than that before treatment (P <0.05), and the difference was statistically significant compared with that of the control group after treatment (P < 0.05). Patients in the control group had no significant differences in medication compliance scores compared with those before 3 months (P> 0.05). Conclusion Patients with tuberculosis consolidation therapy have lower adherence to medication and can significantly improve their medication adherence after individual intervention.